At high-stakes table, growing Peninsula biotech antes up with 'fatty-liver' drug

Even before morbidly overweight people lose pounds through gastric bypass surgery — within only a couple days of the procedure — they shed obesity-related diabetes. Tagging the phenomenon to a specific hormone led to the founding 10 years ago of NGM Biopharmaceuticals Inc. The company developed its own version of the hormone, engineering out the hormone's connection to a hig her risk of liver cancer. Trending: Meet the 130 Best Places to Work in the Bay Area 2017 But instead of pushing forward…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news